4.6 (630) In stock
Familiarize yourself with KADCYLA® (ado-trastuzumab emtansine) preparation and storage in HER2+ early breast cancer. See Full Safety and Boxed Warnings for more information.
Clinical Trial Results in EBC KADCYLA® (ado-trastuzumab emtansine)
WO2015164665A1 - Methods of treating early breast cancer with
PDF) Antibody-drug conjugates in HER2-positive breast cancer
Targeted therapeutic options and future perspectives for HER2
Cancer Therapy Advisor March/April 2018 Issue by Haymarket Media
Kadcyla (ado-trastuzumab emtansine) dosing, indications
Kadcyla (ado-trastuzumab emtansine) - 160 mg Vial For Injection
Ado-Trastuzumab Emtansine (Kadcyla)
KADCYLA- ado-trastuzumab emtansine injection, powder, lyophilized
Trastuzumab - wikidoc
Targeted therapeutic options and future perspectives for HER2
Ado-trastuzumab emtansine (Kadcyla) Drug Information
